CONNECT WITH US
Tech

Tech

Trump abandons his FDA nominee, and Senate scraps vote on his NSF pick

Ars Technica - Tech logo

Published on

Add as a preferred source on Google
Trump abandons his FDA nominee, and Senate scraps vote on his NSF pick

In the span of less than 24 hours, two Trump administration nominees have suffered sudden blows—Trump's pick to lead the Food and Drug Administration and his pick to lead the National Science Foundation.

Late Tuesday evening, Axios reported that the White House had abruptly withdrawn its controversial nomination of Heidi Overton to lead the FDA. Overton, a top conservative domestic policy aide in the White House, has drawn criticism and skepticism from Republicans and Democrats alike over her stances on vaccines, abortion, vapes, and birth control. Overton opposes abortion—though perhaps not strongly enough for some Republicans—and supported Trump and Kennedy's decried anti-vaccine policies and statements, vexing Democrats.

In her confirmation hearing in September, Overton consistently stonewalled senators on every topic, refusing to directly answer even softball questions from friendly Republicans, leaving lawmakers on both sides of the aisle openly frustrated. The questions she dodged included those on how she would handle the FDA's current safety review of the abortion pill, mifepristone, which extensive data has established is extremely safe. She also wouldn't say whether she agreed with Trump when he falsely claimed the measles vaccine is "quite lethal" or that children are given vaccine doses the "size of a soda bottle." Overton repeatedly refused to answer whether Trump could ever be wrong.



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.